ArticleMethods in enzymology2025
Induro-seq to analyze subcellular enrichment of small RNAs.
Article in Methods in enzymology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Small non-coding RNAs, including microRNAs (miRNAs) and tRNA fragments (tRFs), play critical roles in gene regulation across diverse biological contexts. Although miRNAs and tRFs are traditionally viewed as cytoplasmic effectors, recent studies suggest they may also adopt functions within the nucleus. However, accurately mapping the subcellular localization of small RNAs remains technically challenging due to inherent biases in RNA yield between the nuclear and cytoplasmic compartments, as well as the presence of base-pair-disrupting RNA modifications. Here, we present a method for small RNA sequencing in example glioblastoma (GBM) cell lines that enables accurate subcellular localization by integrating defined synthetic spike-in controls and Induro-RT, a highly processive reverse transcriptase capable of reading through modified nucleotides. Spike-in controls correct for input disparities across compartments, while Induro-RT allows for the transcription of modified small RNAs, which are often overlooked by conventional reverse transcriptases. This approach enables unbiased detection of both canonical and modified small RNAs, providing a more accurate and comprehensive view of miRNA and tRF distribution between the nucleus and cytoplasm.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.